EXUMA Biotechnology - Ownership and Business Overview

Life ScienceCompany

EXUMA Biotechnology Ownership

Who owns EXUMA Biotechnology?

EXUMA Biotechnology is owned by F1 Oncology. It was acquired on November 13, 2018.

EXUMA Biotechnology Business Overview

Where is EXUMA Biotechnology headquartered?

EXUMA Biotechnology is headquartered in Grand Cayman, Cayman Islands.

What sector is EXUMA Biotechnology in?

EXUMA Biotechnology is a life science company.

When was EXUMA Biotechnology founded?

EXUMA Biotechnology was founded in 2016.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Join Mergr to view all 247 acquisitions of life science companies in 2018, including 45 acquisitions by private equity firms, and 202 by strategics.

EXUMA Biotechnology

BritCay House 236 Eastern Ave,
Grand Cayman,
Cayman Islands,
+345-232-0566
www.exumabio.com

EXUMA Biotechnology is a clinical-stage biotechnology company developing CAR-T solutions for the solid tumor markets in Asia. EXUMA oversee the development, manufacturing, quality, clinical, regulatory, and commercial operating units located in Shanghai and Shenzhen, PRC.


 Subscribe to unlock this and 202,424
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for EXUMA Biotechnology

Life Science Companies , Cayman Islands Companies